1. Bray F, Ferlay J, Soerjomataram I, et al. (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin, 68(6): 394-424. [ DOI:10.3322/caac.21492] [ PMID] 2. Armoogum KS and Thorp N (2015) Dosimetric comparison and potential for improved clinical outcomes of paediatric CNS patients treated with protons or IMRT. Cancers 7: 706-722. [ DOI:10.3390/cancers7020706] [ PMID] [ ] 3. Peach K, Finst P, Wilson P, Jones B (2011) Accelerator science in medical physics. The British Journal of Radiology, 84: S4-S10. [ DOI:10.1259/bjr/16022594] [ PMID] [ ] 4. Nikolai K and Lev D (2011) Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in-vivo studies. Chem So Rev, 40: 1647-1671. [ DOI:10.1039/C0CS00018C] [ PMID] 5. Lorenzo T (2021) Physical aspects of gold nanoparticles as cancer killer therapy. Indian J Phys, 95: 225-234. [ DOI:10.1007/s12648-019-01679-1] 6. Tabbakh F and Hosmane NS (2020) Enhancement of radiation effectiveness in proton therapy: Comparison between fusion and fission methods and further approaches. Sci Rep, 10: 5466. [ DOI:10.1038/s41598-020-62268-5] [ PMID] [ ] 7. Dimitriou NM, Tsekenis G, Balanika EC, et al. (2016) Gold nanoparticles, radiations and the immune system: Current insights into the physical mechanisms and the biological interactions of this new alliance towards cancer therapy. Nuclear Instruments and Methods in Physics Research B, 373: 126-139. 8. Kim JK, Seo S-J, Kim H-T, et al. (2012) Enhanced proton treatment in mouse tumors through proton irradiated nanoradiator effects on metallic nanoparticles. Phys Med Biol, 57: 8309-8323. [ DOI:10.1088/0031-9155/57/24/8309] [ PMID] 9. Rezaei H, Zabihzadeh M, Ghorbani M, et al. (2017) Evaluation of dose enhancement in presence of gold nanoparticles in eye brachytherapy by 103Pd source. Australas Phys Eng Sci Med, 40: 545-553. [ DOI:10.1007/s13246-017-0555-1] [ PMID] 10. Rahman WN, Bishara N, Ackerly T, et al. (2009) Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy, Nanomed. Nanotech, 5: 136-142. [ DOI:10.1016/j.nano.2009.01.014] [ PMID] 11. Lacombe S, Porcel E, Scifoni E (2017) Particle therapy and nanomedicine: state of art and research perspectives. Cancer Nano 8, 9 [ DOI:10.1186/s12645-017-0029-x] [ PMID] [ ] 12. Wayne D Newhauser and Rui Zhang (2015) The physics of proton therapy. Phys Med Biol, 60: R155-R209. [ DOI:10.1088/0031-9155/60/8/R155] [ PMID] [ ] 13. Liu H and Chang JY (2011) Proton therapy in clinical practice. Chin J Cancer, 30: 5. [ DOI:10.5732/cjc.010.10529] [ PMID] [ ] 14. Fracchiolla F, Lorentini S, Widesott L, et al. (2015) Characterization and validation of a Monte Carlo code for independent dose calculation in proton therapy treatments with pencil beam scanning. Phys Med Biol, 60: 8601-8619. [ DOI:10.1088/0031-9155/60/21/8601] [ PMID] 15. Sea A, John A, Amako K, et al. (2003) Geant4-a simulation toolkit. Nucl Instrum Methods Phys Res A, 506: 250-303. [ DOI:10.1016/S0168-9002(03)01368-8] 16. Allison J, Amako K, Apostolakis J, et al. (2016) Recent developments in Geant4. Nucl Instrum Methods Phys Res A, 835: 186-225. [ DOI:10.1016/j.nima.2016.06.125] 17. Bernal MA and Liendo JA (2009) An investigation on the capabilities of the PENELOPE MC code in nanodosimetry. Med Phys, 36(2): 620-5. [ DOI:10.1118/1.3056457] [ PMID] 18. Report 85 (2011) Fundamental quantities and units forionizing radiation. J ICRU, 11(1): 1-31. [ DOI:10.1093/jicru_ndr028] [ PMID] 19. IAEA TRS 461 Relative Biological Effectiveness in Ion Beam Therapy, International Atomic Energy Agency, 2008. 20. De Napoli M, Agodi C, Battistoni G, et al. (2012) Carbon fragmentation measurements and validation of the Geant4 nuclear reaction models for hadrontherapy. Phys Med Biol, 57(22): 7651-7671. [ DOI:10.1088/0031-9155/57/22/7651] [ PMID] 21. Jerimy CP and Wayne DN (2005) Calculations of neutron dose equivalent exposures from range-modulated proton therapy beams. Phys Med Biol, 50: 3859-3873. [ DOI:10.1088/0031-9155/50/16/014] [ PMID] 22. Ono Takashi, Yabuuchi Tomonori, Nakamura Tatsuya, et al. (2017) High dose hypofractionated proton beam therapy is a safe and feasible treatment for central lung cancer. Radiol Oncol, 51(3): 324-330. [ DOI:10.1515/raon-2017-0023] [ PMID] [ ] 23. Cho J, Gonzalez-Lepera C, Manohar N, et al. (2016) Quantitative investigation of physical factors contributing to gold nanoparticle-mediated proton dose enhancement. Phys Med Biol, 61: 2562-2581. [ DOI:10.1088/0031-9155/61/6/2562] [ PMID] 24. Ferguson S, Ahmad S, Ali I (2020) Simulation study of proton arc therapy with the compact single-room MEVION-S250 proton therapy system. Journal of Radiotherapy in Practice, 19(4): 1- 8. [ DOI:10.1017/S1460396919000888] 25. Belamri C, Amine Dib AS, Ahmed HB (2016) Monte Carlo simulation of proton therapy using bio-nanomaterials. Journal of Radiotherapy in Practice, 15: 290-295. [ DOI:10.1017/S1460396916000145]
|